Daily Stock List
Wolverine Exploration, Inc. (WOLV)
OTCPicks and Willy Wizard reported previously on Wolverine Exploration, Inc. (WOLV), and today we are highlighting the Company as “One to Watch” next week here at the QualityStocks Daily Newsletter.
Wolverine Exploration, Inc. is a junior exploration company that engages in the acquisition and exploration of base and precious metal mineral properties. They focus on the exploration of mineral properties in Labrador, Canada. Wolverine has not yet determined whether the Labrador claims contain mineral reserves that are economically recoverable.
The Company holds a 90 percent interest in 429 mineral claims. These claims cover an area of approximately 10,725 hectares (41 square miles) in central Labrador. The Labrador Claims are approximately 120 kms west of Goose Bay, Labrador. They contain a series of significant copper-gold showings. Pertaining to infrastructure and build-out, a year-round road traverses the property. The property is 68 miles to the nearest deep water port. In addition, a power line is within easy access and the property has near surface anomalies.
Wolverine Exploration concluded exploratory drilling in October 2011. The Company has reassessed their options on their Cache River property in central Labrador. Of the 11 anomalies targeted, only four underwent drilling before the shutdown. The results were not as high as the Company expected and the cause of the anomalies in the drilling area on Grid 1 was determined to be primarily magnetite with minor sulphides. The area drilled does not necessarily reflect the entire property - this was only a small portion of the total claim area.
There remain seven anomalous areas to be investigated. Most of those are 20 kms remote from the 2011 drilling. They are concentrated in the area of the surface malachite showing discovered previously by the Company. There is also a high radiometric and magnetic anomalous area to the northeast. It was detected by the airborne survey that lies under an extensive muskeg where high surface scientillometer readings were noted. Wolverine also considers this a priority 1 target.
The Cache River property drilling program commenced on October 10, 2012. The initial drilling consists of a minimum of four drill holes and a minimum of 300 meters.
Wolverine recently announced that they entered into an Agreement with 0969015 B.C. Ltd. to acquire the Eureka Project Claims in the Caribou Mining District of B.C. The Eureka Project Claims consist of20 mineral tenures -3,910 hectares (9,661 acres). The claims are next to the Wingdam Project. Last month,Wolverine commenced work on the Eureka Project.
Yesterday,Wolverine Exploration announced today that they entered into a Letter of Intent (LOI) with ENIGMAMobil, Inc. to acquire a 25 percent interest in Enigma for a cash payment of USD $10,000,000. Pertaining to the LOI, Wolverine will have 120 days to raise the financing and enter into a formal purchase agreement with Enigma. A cyber security corporation,Enigma possesses the world's only patented technology that can protect against unauthorized computer intrusion and fraud.
We're tracking Wolverine Exploration, Inc. (WOLV) on our radar screens as "One to Watch" this week, here at the QualityStocks Daily Newsletter.
Wolverine Exploration, Inc. (WOLV), closed Friday’s trading session at $0.011, up 15.79%, on 2,486,336 volume with 27 trades. The average volume for the last 60 days is 479,665 and the stock's 52-week low/high is $0.0027/$0.017.
Silver Falcon Mining, Inc. (SFMI)
PennyStocks24, Wallstreetlivechat, and OTCPicks reported earlier on Silver Falcon Mining, Inc. (SFMI), and we report on the Company today, here at the QualityStocks Daily Newsletter.
Listed on the OTC Bulletin Board, Silver Falcon Mining, Inc. engages in the exploration and development of gold and silver properties in the U.S. A junior resource production enterprise, they acquired the rights to develop and operate the mines of GoldLand Holdings, Co., on War Eagle Mountain, on the Owyhee Gold Trend of the Silver City Mining District in southern Idaho. Silver Falcon Mining has their headquarters in Bradenton, Florida.
In addition, the Company is 100 percent owner to the historic Sinker Tunnel and the four mill sites that intersect the main vein of the Oro fino/Golden Chariot vein. The Sinker Tunnel will permitaccess to the mountain year round by way of maintained roads. It will also allow the Company to access possible primary ore reserves via underground mining.
Silver Falcon Mining has mineral rights to approximately 1,200 acres on War Eagle Mountain in southern Idaho. Their Diamond Creek Mill is at the foot of War Eagle Mountain. Initial production on the mountain is scheduled for this 2013 fiscal year, with an estimated 15-20 year life-of-mines. The estimation is that annual yield, at full capacity, will be $ 6.6 million at the price of gold of $1,650.
Last week,Silver Falcon Mining announced that they are proceeding with contract milling services. The Company’s management has been approached by several mining entities within the surrounding states for help in milling, metallurgical processes, milling engineering, as well as other milling related activities.
As of August 23, 2013, a mining concern sent 10 tons of ore bearing materials and a payment of $5,000.00 to Silver Falcon Mining’s 100 percent owned Diamond Creek Mill Facility. The goal of this mining company is to have Silver Falcon process their ore and provide other ensuing metallurgical activities. Silver Falcon Mining,upon satisfactory processing of the test material tonnage,will enter into a full-term contractual agreement that will detail daily tonnages and pay-outs to Silver Falcon for these toll services.
Silver Falcon Mining, Inc. (SFMI), closed Friday at $0.006, down 6.25%, on 577,800 volume with 5 trades. The average volume for the last 60 days is 2,666,565 and the stock's 52-week low/high is $0.003/$0.0375.
WebSafety, Inc. (WBSI)
PennyStocks24, Wallstreetlivechat, eStocks Daily, Pumps and Dumps, and Psionic Matrix reported earlier on WebSafety, Inc. (WBSI), and we are reporting on the Company today, here at the QualityStocks Daily Newsletter.
WebSafety, Inc. markets and sells,by way of the internet, a range of software applications and services for cell phones. These applications and services enable parents or other caregivers to monitor and be notified of occurrences of predator advances, cyber bullying, and pornography received on cell phones. The Company's intention is to market the products and services by developing relationships with "trusted" sources consisting of child protection advocacy groups.
Founded in 2006, WebSafety lists on the OTC Markets' OTCQB.The Company has their corporate headquarters in Newport Beach, California.The Company was previously known as Blindspot Alert, Inc. They changed their name to WebSafety, Inc. in September of 2009.
WebSafety’s cell phone application also restricts text messaging while driving. In addition, it provides location information to parents through using Global Positioning System (GPS) technology. The Company intends to explore opportunities to enter into strategic revenue sharing partnerships with companies having synergy with WebSafety’s products. These partners may include auto insurers and cell phone manufacturers.
WebSafety's advanced database technology can search more than 22,000 words, terms, and phrases that mean danger. WebSafety's technology is the only mobile parental control that contains the world's largest word recognition library of its type. The alerts instantly notify instances of sexting, texting while driving, cyber- bullying, pornography, or predatory conduct.
This past July,WebSafetyannounced that the Company retained the law firm of Knobbe Martens Olson & Bear, LLP to file additional patents to protect WebSafety’s proprietary technology. WebSafety intendsto protect their technology in the U.S.and in other nations.Knobbe Martens Olson & Bear is one of the U.S.’s largest Intellectual Property (IP) law firms.
WebSafety’s mobile software application supports devices using the Android wireless operating system. It operates on all four of the major wireless carriers in the U.S. and the three major wireless carriers in Canada.
WebSafety, Inc. (WBSI), closed Friday's session at $0.0026, down 18.75%, on 6,599,557 volume with 57 trades. The average volume for the last 60 days is 5,102,756 and the stock's 52-week low/high is $0.0008/$0.0065.
South American Gold Corp. (SAGD)
Stock Analyzer reported earlier on South American Gold Corp. (SAGD), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.
South American Gold Corp. is an exploration mining company which lists on the OTC Markets’ OTCQB. The Companyfocuses on the discovery, acquisition, exploration, and development of gold and silver deposits in North America and South America. Their strategy is to acquire a pipeline of mining prospects in historic mining districts to explore, develop, or joint venture (JV), with a goal of establishing commercial production. Their approach is to target historic Gold and Silver mining districts that they consider underexplored.
Founded in 2005, South American Goldhas their corporate headquarters in Richmond, Indiana. In addition, they havean office in Copacabana, Antioquia, Colombia.The Company was previously known as Grosvenor Explorations, Inc. They changed their name to South American Gold on October 11, 2010.
South American Gold owns, leases, or options silver and gold exploration prospects in different U.S. States. These prospects cover over 400 acres; this includes the Company’s flagship Baltimore Silver Mine project. So far, the Company has focused on the Narino Department in the south of Colombia. They are conducting an internal assessment of focusing on the processing side of established or prospective gold projects in this country, with a particularemphasis on Narino.
The Company acquired one, and leased nine, unpatented mining claims covering roughly200 acres of a prospective gold project (Arizona GB Project) in the historic Canyon City Mining District of Yavapai County in Arizona. Additionally, they signed a lease on the New Light Mine project in northern Washington State, considered a Gold and Silver project.
Their Baltimore Silver Mine is a former producing silver mine in an historic mining district positionedon private land in Jefferson County, Montana. The project is 100 acres consisting of 60 acres of patented mining claims and 40 acres of unpatented mining claims. The 60 acres of the mine proper are leased under a renewable lease with an option to purchase, subject to a 3 percent Net Smelter Return (NSR). The 40 unpatented acres are owned and subject to no royalties. The Companyconsiders the Baltimore Silver Mine a potential silver producer.
South American Gold announced in May 2013 that they signed a Memorandum of Understanding (MOU) to acquire an eighty percent interest in the Kelly Project, with an option to acquire a 100 percent interest. The Kelly Project consists of sixteen unpatented mining claims in western Montana. The Company considersthe Kelly group of mining claims to have the the potential for small scale production.
South American Gold Corp. (SAGD), closed at $0.0011, up 10.00%, on 8,156,537 volume with 27 trades. The average volume for the last 60 days is 7,647,460 and the stock's 52-week low/high is $0.0008/$0.0069.
Corgenix Medical Corp. (CONX)
MicroCap Gems and Stock Fortune Teller reported previously on Corgenix Medical Corp. (CONX), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Corgenix Medical Corp. is a leader in the development and manufacturing of specialized diagnostic kits for immunology disorders, vascular diseases, and bone and joint disorders. This includes the world’s only non-blood-based test for aspirin effect. In addition,the Company contract develops and manufactures (in state-of-the-art facilities in Colorado) products for key medical and life science companies.
Listed on the OTCQB, Corgenix Medical has their headquarters inBroomfield Colorado.Corgenix was the first commercial company in the U.S. to develop and manufacture the anticardiolipin assay used in the detection of several autoimmune and vascular diseases.
The Company’sdiagnostic products are commercialized for use in clinical laboratories worldwide. Presently, Corgenix sells greater than 50 diagnostic products via a global distribution network. The Company provides global marketing for these products through direct and indirect sales and distribution channels. Furthermore, Corgenix has considerable experience in product submissions to the Food and Drug Administration (FDA) and other international regulatory authorities.
Recently, Corgenix Medicalannounced that they entered into a contract manufacturing agreement with EDP Biotech. Pertaining to this 10-year agreement, Corgenix will manufacture and supply the ColoMarker™ diagnostic test, a blood test developed to detect the early stages of colon cancer. ColoMarker™ requires no advance preparation by the patient such as fasting or colon cleansing. ColoMarker™ can be added easily to the panel of blood tests normally performed at a patient’s yearly physical.
EDP Biotech is a medical device company focused on the development and commercialization of immunodiagnostic tests for humans. Corgenix recently announced the expansion of their Contract Services business unit.
This week,Corgenix announced that they closed on a $1.5 million secured revolving line of credit with Bank of the West. The new revolving line of credit provides Corgenix a very favorable interest rate and far greater flexibility than the prior asset-based revolving line of credit.The Company will use the new line of credit for general working capital purposes.
Corgenix Medical Corp. (CONX), closed Friday’s trading session at $0.1999, even for the day. The average volume for the last 60 days is 22,826 and the stock's 52-week low/high is $0.01/$0.247.
Stevia First Corp. (STVF)
Paragon Report and Investor Ideas reported earlier on Stevia First Corp. (STVF), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.
A development-stage agri-bio business, Stevia First Corp.focuses on thecultivation of stevia, which is an all-natural zero-calorie sweetener. The Company is working to establish a vertically-integrated business in the United States that uses technological expertise in fermentation-based stevia production and improves upon traditional stevia farming and processing methods.
Stevia First lists on the OTCQB and the Company has their headquarters in Yuba City, California. Stevia First's U.S. operations are in the heart of California's Central Valley.The Company was previously known as Legend Mining, Inc. They changed their name to Stevia First Corp. in October of 2011.
Stevia is a plant from the sunflower family that is native to Paraguay.The leaf of the stevia plant has 9 to 12 sweet-tasting compounds. These are known as steviol glycosides, including Stevioside (STV) and Rebaudioside A, the sweetest and best tasting of the compounds. Stevia plant leaves are the source of safe, natural, zero-calorie extracts used as sweeteners.
The Company’sresearch and development will concentrateon high-value research and development targets (including fermentation-based stevia production methods) which may reduce the need for stevia leaf production. Moreover, Stevia First work’s to breedadvanced varieties of the stevia plant. They willwork to develop stevia products that optimize sweetness levels, taste, adaptability, and ease of production.
Recently,Stevia Firstannounced that the Company is building support and acceptance for stevia. They are doing thisthroughincreasingtheir involvement within the U.S. Departments of Agriculture’s(USDA's) IR-4 Program and helping provide domestic stevia growers with tools for long-term, reliable stevia leaf production.In May 2013, the herbicides Envoy (Clethodim), Dual Magnum (S-Metolachlor), and Prowl H20 (Pendimethalin), received commercial and manufacturer support to be elevated to high priority status in the Western Region's IR-4 Program. This prioritization change was facilitated by Stevia First acting in tandem with researchers from the USDA, UC Davis, and North Carolina State University.
This week,Stevia Firstannounced plans for a stevia tasting event in December 2013. The event isintended to showcase the Company's stevia product innovations. This includes the first public tasting of their newly branded product, Nature-Identical™ Stevia.
Stevia First Corp. (STVF), closed Friday’s trading session at $0.3203, up 0.09%, on 154,520 volume with 47 trades. The average volume for the last 60 days is 82,240 and the stock's 52-week low/high is $0.30/$0.84.
Elite Pharmaceuticals, Inc. (ELTP)
SmallCap Network, PennyStocks24, Pennybuster, SmarTrend Newsletters, Greenbackers, OTCBB Journal, First Penny Picks, and Real Pennies reported earlier on Elite Pharmaceuticals, Inc. (ELTP), and we report on the Company as well, here at the QualityStocks Daily Newsletter.
Elite Pharmaceuticals, Inc. is a specialty pharmaceutical company that lists on the OTC Bulletin Board. The Companydevelops oral sustained and controlled release products.Elite Pharmaceuticals has their headquarters in Northvale, New Jersey.The Company operates a GMP and DEA registered facility for research, development, and manufacturing located in Northvale.
Elite Pharmaceuticals has six commercial products nowselling, an additional product approved and soon to be launched, and11 approved products pending manufacturing site transfer. The Company also has two additional products under review pending approval by the Food and Drug Administration(FDA).
The Company’s lead pipeline products include abuse resistant opioids utilizing Elite’s patented proprietary technology, and a once-daily opioid. They are sustained release oral formulations of opioids for the treatment of chronic pain. They address two of the limitations of existing oral opioids: the provision of consistent relief of baseline pain levels and deterrence of potential abuse.
In addition, Elite Pharmaceuticals provides contract manufacturing for Ascend Laboratories (a subsidiary of Alkem Laboratories Ltd.). Elite also has partnered with Mikah Pharma to develop a new product; with Hi-Tech Pharmacal to develop an intermediate for a generic product, and with a Hong Kong-based company to develop a branded product for the U.S. market and its territories.
Recently,Elite announced results for the first quarter of fiscal year 2014, ended June 30, 2013.Manufacturing and profit split revenues consisting of almost all of the Company’s quarterly revenues and totaled $717k for the quarter. This represents an increase of 41 percent from the previousyear.
The Company attributes this growth to the introductionof two new products during the quarter, Phentermine 15mg and 30mg capsules, combined with strong year-on-year growth of their Hydromorphone 8mg tablets and contract manufactured Methadone 10mg product lines.
This week,Elite Pharmaceuticals announced that the Company will be featured as a presenting company at the 15th Annual Rodman & Renshaw Global Investment Conference, sponsored by H.C. Wainwright & Co., LLC. The conference will take place September 8-10, 2013, at the Millennium Broadway Hotel in New York, New York.
Elite Pharmaceuticals, Inc. (ELTP), closed Friday at $0.0815, up 1.88%, on 1,006,742 volume with 77 trades. The average volume for the last 60 days is 1,323,804 and the stock's 52-week low/high is $0.0507/$0.143.
Pharmagen, Inc. (PHRX)
Stocks Gone Wild reported recently on Pharmagen, Inc. (PHRX), Investors Online Bell, StocksFor2010.com did earlier, and today we highlight the Company, here at the QualityStocks Daily Newsletter.
Pharmagen, Inc. consists of wholly owned subsidiaries and operating divisions Pharmagen Laboratories, Inc. (Labs), Pharmagen Distribution, LLC, and Pharmagen Nutraceuticals, Inc. Based in Silver Spring, Maryland, the Company previously went by the name Sunpeaks Ventures, Inc. They changed their name to Pharmagen, Inc. in January of this year. Pharmagen’s shares trade on the OTC Bulletin Board.
Pharmagenis the leader in advancedsolutions to the nation’s sterile pharmaceutical shortage crisis.The Company notes that theU.S.’s current drug supply crisis is being driven by raw material shortages and low reimbursement rates.
As a result, this causes manufacturers to discontinue production because of continuingdeclining margins.Furthermore, a small number of pharmaceutical manufacturers dominate sterile production in the U.S. That number has decreasedas more companiesleave the industry to pursue higher margins and intellectually protected, branded pharmaceuticals. Consequently, this limits competition.
Pharmagen Laboratories’ (Labs) specialties include urology, pain management, hormone replacement, ophthalmology, respiratory diseases, mental and psychological disorders, and oncology. Labs’ specialities additionally include gynecology, muscular and skeletal locomotion (MS), trauma and burn units, neo-natal compounding, hypoallergenic compounding, and veterinary compounding.
Pharmagen Distribution is a national specialty pharmaceutical distribution company. Theyserve multi-specialty clinics, surgery centers, and physicians. Their products include full-line brand pharmaceuticals, injectables, vaccines, and a generics portfolio.Pharmagen offers a complete line of products including plasma derivatives, oncology, women’s health, vaccines, surgical, and orthopedic.
Pharmagen Nutraceuticals manufactures and distributesOver-the-Counter (OTC) branded health supplements. Theirfirst OTC product, Clotamin™, is available countrywide.Clotamin is a multivitamin; it is specifically formulated for patients with blood clotting disorders who take blood thinners such as warfarin (Coumadin).At present, the Company is analyzing a number of OTC products that would allow them to become a strongplayer in the multi-billion-dollar health supplementmarketplace.
Pharmagen’s long term goal is to become a Food and Drug Administration(FDA) approved manufacturer of habitually short supply, sterile pharmaceuticals. The Company’s goal is tobe the gold standard of sterile production in the U.S.,through a pioneering, cGMP + ® process, employing single-use, modular systems.
Pharmagen, Inc. (PHRX), closed Friday’s trading session at $0.02, even for the day, on 1,017,290 volume with 34 trades. The average volume for the last 60 days is 317,714 and the stock's 52-week low/high is $0.015/$0.095.
Calpian, Inc. (CLPI)
The QualityStocks Daily Newsletter would like to spotlight Calpian, Inc. (CLPI). Today, Calpian, Inc. closed trading at $1.30, off by 7.14%, on 5,500 volume with 1 trade. The stock’s average daily volume over the past 60 days is 2,925, and its 52-week low/high is $0.88/$2.75.
Calpian, Inc. announced today that Harold Montgomery, Chairman and CEO of CLPI, will be presenting at the Rodman & Renshaw Annual Global Investment Conference on Monday, September 9, at 4:05 p.m. ET in Room 5.08 of the Millennium Broadway Hotel in New York. Mr. Montgomery will provide a brief overview of the company's business and will be available for a Q&A session after the presentation. as well as staying on-hand afterwards for one-on-one meetings with investors attending the conference. For more information about the Rodman & Renshaw Global Investment Conference, please refer to the conference website HERE.
Calpian, Inc. (CLPI) has forged a powerful combination of steady cash flow here in the U.S. on the one hand, and explosive growth potential abroad in India on the other. Both business units are growing fast and creating huge value that has so far gone largely overlooked due to the company’s rapid rise.
Calpian is a leader in the U.S. business for providing access to credit and debit card payment processors for merchants and also for making investments in the resulting cash flow streams. Calpian's management team, with over 60 years of combined experience in payments, has also tapped into a super-hot growth opportunity in India where it is the leader in consumer payments using the cell phone - the most powerful financial trend in the developing world today. The company's revenues in India grew 300% year to year and are headed for triple digit growth again in 2013. Examples of this service in other countries like Kenya show that consumers need this simple payment tool and adopt it quickly. In Kenya, over 90% of the adult population has adopted a mobile phone money transfer system known as M-PESA, which produces over $100 million pretax profit after only 7 years in business. Calpian is providing this same service in India via Money on Mobile (MoM). India is a market at least 30 times larger than Kenya with vast potential. Calpian is the undisputed market leader in the space and looks poised to dominate the largest market for this service in the world with almost 1 billion cell phones.
In the U.S., the company has carved out a solid niche in the growing $1B plus annual residuals space for credit card usage by providing a silver bullet solution including their own gateway that merchants use to connect with large payment processors. Calpian is providing its merchant services through its wholly owned subsidiary, Calpian Commerce continues to sign merchants to card processing contracts, while Calpian itself continues acquiring additional recurring monthly cash flows from the over 10,000 smaller Independent Sales Organizations (dealers) throughout the U.S. The management team has been together for decades refining this business model through over 200 acquisitions in their careers before making it public in 2010. The team is experienced and well known throughout the industry as the go-to guys for making a deal.
In India, with Calpian acquiring an interest in March 2012 in Digital Payments Processing Limited (DPPL), which delivers the payment processing service for the Money on Mobile solution, it has taken off with incredible force, signing an incredible 53 million consumers though its vast network of 143,000 retailers (and growing at least 3,000 per month) so far. This astonishing growth is thanks in large part to how elegantly the company's mobile payment application, which is already seen as the “PayPal” of India, satisfies all the needs of the average Indian consumer, distributor, and retailer alike. The vast swathes of under-banked and unbanked consumers in India represent the tip of a much larger global iceberg for this solution as well, a solution whose backbone is simple SMS text protocol, and which bundles all the right incentives together for emerging markets. MoM is the runaway leader at this time in India pacing at 20 times larger than its nearest competitor. Disclaimer
Calpian, Inc. Company Blog
Calpian, Inc. News:
Calpian to Present at the 15th Annual Rodman and Renshaw Conference
Calpian’s Money-on-Mobile Grows to Serve over 57 Million Unique Users
CALPIAN’S Money-on-Mobile Serves over 53 Million Unique Users
Advaxis, Inc. (ADXS)
The QualityStocks Daily Newsletter would like to spotlight Advaxis, Inc. (ADXS). Today, Advaxis, Inc. closed trading at $4.10, up 6.49%, on 20,127 volume with 40 trades. The stock’s average daily volume over the past 60 days is 6,089, and its 52-week low/high is $2.60/$19.375.
Advaxis, Inc. (ADXS) is a clinical-stage biotechnology company developing the next-generation of immunotherapies for cancer and infectious diseases. The company’s immunotherapies are based on a novel platform technology that uses live, bio-engineered bacteria to secrete an antigen/adjuvant fusion protein that redirects the powerful immune response all human beings have to fight off cancer and disease.
The company has more than fifteen distinct constructs in various stages of development, all of which are involved in strategic collaborations with recognized centers of excellence such as the National Cancer Institute, Cancer Research – UK, the Wistar Institute, the University of Pennsylvania, the University of British Columbia, the Karolinska Institutet, and others.
Advaxis’ lead construct, ADXS-HPV, is currently in Phase 2 clinical development for recurrent/refractory and advanced cervical cancer, CIN 2/3, and HPV caused head and neck cancers. This important construct was recognized as the Best Therapeutic Vaccine (approved or in development) at the 5th Annual Vaccine Industry Excellence (ViE) Awards by the vaccine industry and the journal Expert Reviews of Vaccines.
The estimated global market for immunotherapies is projected to exceed $37.2B by 2012, with cancer vaccines forecast to grow into an $8B market. Protected by 77 issued and pending patents, Advaxis is extremely well positioned to capitalize on the burgeoning opportunities in the healthcare sector as it advances the development of next-generation treatments for today’s most challenging diseases. Disclaimer
Advaxis, Inc. Company Blog
Advaxis, Inc. News:
Advaxis Lead Product Candidate ADXS-HPV in Combination with PD-1 Antibody Significantly Improves Immune and Therapeutic Efficacy in Preclinical Study
Advaxis Announces Three Abstracts Accepted for Presentation at Society for Immunotherapy of Cancer Annual Meeting
Advaxis Appoints Daniel J. O’Connor President and CEO and Elects Dr. James Patton Non-Executive Chairman of the Board
Consorteum Holdings, Inc. (CSRH)
The QualityStocks Daily Newsletter would like to spotlight Consorteum Holdings, Inc. (CSRH). Today, Consorteum Holdings, Inc. closed trading at $0.0084, up 55.56%, on 212,000 volume with 2 trades. The stock’s average daily volume over the past 60 days is 370,059, and its 52-week low/high is $0.0015/$0.12.
Consorteum Holdings, Inc. (CSRH) utilizes the most technically advanced global solutions available today. By working with a multitude of global technologies, Consorteum is able to create customized programs for maximum results. This approach enables unparalleled flexibility when sourcing solutions, resulting in smarter, faster deployment of technologies, competitive pricing, and potential for new streams of revenue.
Through its exclusive software license with Tarsin Inc., the company leverages a team of software developers that understands the complexities of delivering digital media content across mobile handsets. Tarsin is capable of providing clients with integration and support for over 700 mobile carriers globally on a seamless and secure platform to take advantage of the increasing demand for rich mobile content.
Consorteum's flagship CAPSA technology platform brings a universal solution to the problems of wagering and betting on mobile devices. Multiple different operating systems, user interfaces, and form factors have created enormous barriers to launching commercial initiatives. But with CAPSA, gaming operators can now cost-effectively monetize innovative mobile wagering products and services quickly and robustly.
In addition to its mobile initiatives, Consorteum is also actively engaged in the financial industry, providing MasterCard solutions as well as loyalty and reward programs. The company has strategically designed its business initiatives to create repetitive transactions on an ongoing basis. Consorteum's goal is to have their customers think of them more as partners, rather than just technology providers, for longer-lasting, more profitable relationships. Disclaimer
Consorteum Holdings, Inc. Company Blog
Consorteum Holdings, Inc. News:
Consorteum Holdings Inc. and The Alternative Initiate New Brand Development Project
Consorteum Holdings Inc. Forms a New, Wholly Owned Subsidiary
Consorteum Holdings, Inc. Appoints Olde Monmouth Stock Transfer Company as New Transfer Agent
Raptor Resources Holdings Inc. (RRHI)
The QualityStocks Daily Newsletter would like to spotlight Raptor Resources Holdings Inc. (RRHI). Today, Raptor Resources Holdings Inc. closed trading at $0.02, up 17.65%, on 326,949 volume with 7 trades. The stock’s average daily volume over the past 60 days is 156,582, and its 52-week low/high is $0.0002/$0.0395.
Raptor Resources Holdings Inc. (RRHI) is a publicly traded holdings company focused on mineral resource acquisition, exploration, and development. The company currently has two subsidiaries: Mabwe Minerals Inc. (MBMI), a natural resources and hard asset company engaged in the mining and commercial sales of industrial minerals & metals with first focus on barite; and TAG Minerals Inc., a mineral & metal resource acquisition, exploration, and development company with first focus on alluvial surface gold.
Mabwe Minerals has been the focus of the parent company’s efforts the last two years to move into commercial barite production. RRHI shareholders share a common interest with MBMI shareholders in the success of Dodge Mine as the parent company owns 90M shares of MBMI. The Dodge Mine property consists of three hydrothermal mountains representing 123 hectares containing multiple deposits of superior-grade barite, limestone, and talc.
TAG Minerals, along with its indigenous affiliate, TAG Minerals Zimbabwe (Private) Limited, is responsible for alluvial gold production along with the development of greenfield assets targeting bedrock gold and other potential metals & minerals. As MBMI is transitioning into commercial barite production, RRHI will now focus on building assets within TAG Minerals with the intent of moving into commercial production within the next 18 months. TAG Minerals will utilize the latest in Heavy Particle Concentrators (HPC-30/HPC-100) through its relationship with Extrac-TEC whose gold recovery and mineral separation technology captures up to 98% of alluvial gold down to 50 microns. The company is in early stage exploration evaluating potential alluvial sites to ensure they meet the company's criteria for commercial production. Coupled with MBMI's acquisition of WGB Kinsey & Company, TAG Minerals is well positioned to fast track into commercial production once the company has successfully completed its exploratory testing.
RRHI management continues to improve its balance sheet as reflected in the company's SEC 10k filing, including favorable reductions in the company's debt/liabilities and securing 54.4M shares and 14.4M warrants of RRHI from prior employees. The company is committed to growing its asset base in TAG Minerals moving forward. Disclaimer
Raptor Resources Holdings Inc. Company Blog
Raptor Resources Holdings Inc. News:
Mabwe Minerals Commences Mining Operations at Dodge Mine
Mabwe Minerals Frames Strategic Alliances With Steinbock Minerals Ltd. and Yasheya Ltd.
Mabwe Minerals Inc. Announces Engagement of QualityStocks Investor Relations Services
Earlier today, Calpian announced that its Chairman and Chief Executive Officer will be presenting at the Rodman & Renshaw Annual Global Investment Conference on Monday, September 9, 2013 at 4:05 p.m. ET in Room 5.08 of the Millennium Broadway Hotel in New York.
The Calpian executive will provide a brief overview of the company’s business and will be available for a Q&A session after the presentation. He will also be available for one-on-one meetings with investors attending the conference.
The Calpian presentation will be webcast live and archived for later replay. To access the webcast, please visit the investor page on the company’s website at www.calpian.com. A replay of the presentation will be archived after the conference at the same location.
For more information about the Rodman & Renshaw Global Investment Conference, please refer to the conference website at http://www.meetmax.com/sched/event_20174/
To learn more about Calpian, visit www.calpian.com
Raptor Resources operates through two subsidiaries: Mabwe Minerals, Inc. (OTCQB: MBMI), a publicly traded natural resources and hard asset company engaged in the mining and commercial sales of industrial minerals & metals with first focus on barite; and TAG Minerals, a mineral & metal resource acquisition, exploration, and development company with a primary focus on alluvial surface gold.
While RRHI temporarily halted TAG projects and worked to successfully bring into production MBMI’s barite and limestone production at its Dodge Mine in Zimbabwe, the company is now in position to get TAG back on track in developing greenfield assets targeting bedrock gold.
Jim Cramer Thursday told CNBC he expected a rise in gold prices due to the strikes in South Africa, a widespread sentiment among industry experts who also note expected strength from geo-political factors and seasonal trends. The month of September has historically been gold’s second-best month of the year in terms of performance.
RRHI hasn’t made an official insinuation that it will soon resume activities at TAG projects, though it’s broader aim is to grow both organically and through the acquisition of mining and mineral assets. TAG is positioned with its key partner, Extra-TEC, which utilizes HPC-30 technology to capture up to 90 percent of riverbed gold content down to 50 microns. Through the use of a prospector license, TAG has access to nearly 1,500 acres of the greenfield mountain range for evaluation purposes.
For more information, visit www.raptorresourcesholdings.com
Mining company Mabwe Minerals is profiting from its ongoing successful development of a major world-class Dodge Mine barite deposit in Zimbabwe, Africa. The company’s success has been based to a large degree on its ability to identify and forge key partnerships and contacts in the African and world mining industry. These critical links have helped guide the company’s operations and allowed Mabwe to leverage its significant assets.
Foremost among Mabwe’s valuable set of contacts is the company’s Advisory Board, made up of key company and partner executives, together with industry and area leaders.
• Al Pietrangelo – CEO and President of Mabwe, and Chairman of Mabwe-C, responsible for all USA operations including maintaining compliance with the SEC, all aspects of working within the WallStreet community, and responsible for all acquisitions and mergers in both Zimbabwe and the U.S.
• Tapiwa Gurupira – Director of MBMI, and a Director of Mabwe-C, responsible for all activities associated with the Zimbabwe Mining Authorities and government related entities involving political, social, financial, and environmental issues within the Dodge Mine community
• J. Louis Schlegel IV – VP of Business Development for MBMI, and a Director of Mabwe-C, responsible for the global marketing and sales of Dodge Mine minerals and metals, including maintaining customer relationships and land asset development
• Dean Harrison – An affiliate of MBMI, and a Director of Mabwe-C, responsible for managing the Zimbabwe day-to-day operations of the company, with specific responsibilities for coordinating with PHI Commodities the barite rail wagon shipments to the Port of Beira in Mozambique
• Asswell Gurupira – A Director of Mabwe-C, and a community leader holding the rank of “Sabhuku” (Headman) of Chigede Village in Chiweshe, responsible for ensuring the needs of the Dodge Mine Community are represented and assisting his son Tapiwa in managing all community issues, charities and/or mission related programs
• Anthony Kinsey – Managing Director of WGB Kinsey & Company, responsible for overseeing corporate operations at Dodge Mine, and for providing all the necessary resources to support the long term production requirements of Mabwe Minerals
• Kevin Hegarty – Operating Director of WGB Kinsey & Company, with direct day-to-day responsibility for all operations at Dodge Mine, including building and maintaining long term infrastructure, managing equipment and employee resources, overseeing barite lot qualification and barite transportation to the Shamva Rail Depot through the loading onto rail wagons at the Shamva Rail Depot
• Gary Booth – Director of PHI Commodities, with responsibilities including the coordination of the express train land transportation system for barite/grain with Mabwe-C, along with the expansion of rail transportation capacity
• Graham Roberts – Director of PHI Commodities, responsible for managing the relationships with the National Railway of Zimbabwe (NRZ), the Rail Authorities of Mozambique (CFM) who also own the Port of Beira, and Cornelder who is the leaseholder of the Port of Beira.
For more information about Mabwe Minerals, visit www.dtg.fm/MBMI-Presentation
When an industry changing idea comes along, it isn’t long before people start to recognize its importance and wonder why it wasn’t developed earlier. Such is the case with OxySure Systems, inventors of a revolutionary way to supply oxygen for use in emergency situations, an approach that is safer, simpler to maintain, more affordable, and easier to use than conventional oxygen tanks.
OxySure’s patented system is based upon two dry, inert, proprietary powders, which, when activated, produce medically pure oxygen. There are no compressed oxygen tanks, no dials, no valves, no regulatory maintenance, no hydrostatic testing, no batteries, no required training, and none of the hazards associated with traditional oxygen provision systems. For the first time in history a lay rescuer – a bystander or loved one – can safely administer medical oxygen during those first critical minutes after an emergency occurs, improving outcomes and saving lives.
A recent video out of Colorado Springs, reported on ABC 7 in Denver and other news stations, reveals the potential hazards associated with traditional oxygen canisters (http://dtg.fm/Ctg3). The video, which quickly went viral, shows emergency responders preparing to put out a car fire caused when one car was hit by another. Suddenly the car on fire explodes, shooting debris flying into the air, damaging two police cars and a fire truck. Fortunately nobody was injured, but the cause of the explosion was determined to be oxygen canisters that were being carried in the trunk of the car. Perhaps most telling was a comment about the video left by someone identifying themselves as a former nurse, expressing their concern about all the people now on portable oxygen that do not follow safety guidelines.
OyxSure emergency oxygen systems are safe and easy to use, and are currently found in schools in over 40 states in the U.S., and are now being adopted in many other countries.
For additional information, visit www.oxysure.com
Today's Top 3
Investor News Source
The QualityStocks Public Company Sponsor News
- Get profiles for new featured companies at clients.qualitystocks.net
- Advaxis, Inc. (ADXS) Lead Product Candidate ADXS-HPV in Combination with PD-1 Antibody Significantly Improves Immune and Therapeutic Efficacy in Preclinical Study
- All Grade Mining, Inc. (HYII) Takes Initial Steps to Acquire Second Mining Project in Chile
- Calpian, Inc. (CLPI) to Present at the 15th Annual Rodman and Renshaw Conference
- Consorteum Holdings, Inc. (CSRH) Forms a New, Wholly Owned Subsidiary
- DoMark International, Inc. (DOMK) Increases Holding in Imagic Ltd. Ahead of SmartLink Global Launch
- Dragon Capital Group Corp. (DRGV) Subsidiary to Participate in National Science and Technology Research Project Focusing on Large Scale Programmable Logic Controllers
- Epazz Inc. (EPAZ) Reaches Over 60 Million Shares on Short Sales Report for August 2013
- GlobalWise Investments, Inc. (GWIV) to Present at Solutions Exchange Conference
- GNCC Capital, Inc. (GNCP) Potential Low Cost Mining at Gold Hills Property
- Intelimax Media, Inc. (IXMD) Corporate Update
- International Stem Cell Corp. (ISCO) to Present at Rodman & Renshaw 15th Annual Global Investment Conference September 8th to 10th
- Mabwe Minerals Inc. (MBMI) Completes Strategic Alliances With Steinbock Minerals Ltd. and Yasheya Ltd.
- Max Sound Corp. (MAXD) HD Audio Technology Debuts At Qualcomm's Uplinq™ 2013 Wireless Ecosystem Conference
- Midwest Energy Emissions Corp. (MEEC) to Present at the Southern California Investor Conference
- NanoTech Entertainment, Inc. (NTEK) Entertainment to Stream the International Wine Channel TV Awards Live
- On The Move Systems Corp. (OMVS) Online Travel Industry Booms
- OxySure Systems, Inc. (OXYS) Taglich Brothers Reiterates Speculative Buy Rating
- Rafarma Pharmaceuticals, Inc. (RAFA) New Dialysis Research and Development Center to Join Rafarma in Making Terbuny Russia's New Biotech Hub
- Raptor Resources Holdings Inc. (RRHI) Mabwe Minerals Commences Mining Operations at Dodge Mine
- Solar Wind Energy Tower, Inc. (SWET) Wall Street Transcript Interview with Ronald W. Pickett, the President, CEO and Chairman of Solar Wind Energy Tower, Inc.
- StreamTrack, Inc. (STTK) Announces Cancellation of Potential $2.5 Million Royalty Liability
- VistaGen Therapeutics, Inc. (VSTA) Provides Update on $36 Million Strategic Financing Agreement